Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas

INTRODUCTION: Despite many efforts to develop new chemotherapies for metastatic upper gastrointestinal (GI) cancer, overall prognosis continues to be fatal, particularly in gastric and pancreatic cancer. Many of these patients deserve second-or third-line treatment after failure of first-line chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprinzl, Martin F., Wytopil, Sonia M., Dahmen, Anja, Kanzler, Stephan, Galle, Peter R., Moehler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161696/
https://www.ncbi.nlm.nih.gov/pubmed/21892332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161696/
https://www.ncbi.nlm.nih.gov/pubmed/21892332

Ejemplares similares